Gilead's Remdesivir First Drug to Win FDA Approval for Coronavirus

Eric Volkman, The Motley Fool
·2 min read
Gilead's Remdesivir First Drug to Win FDA Approval for Coronavirus
Gilead's Remdesivir First Drug to Win FDA Approval for Coronavirus

On Thursday, the U.S. Food and Drug Administration (FDA) granted approval to Gilead Sciences' (NASDAQ: GILD) remdesivir -- sold under the brand name Veklury -- to treat the illness in patients 12 years of age and older in cases requiring hospitalization. Gilead is currently developing an inhaled version. The FDA's approval was based on data from three clinical studies of the drug.